MediPal Holdings Corporation (TYO: 7459)

Japan flag Japan · Delayed Price · Currency is JPY
2,655.00
+11.50 (0.44%)
Sep 9, 2024, 3:15 PM JST
5.23%
Market Cap 552.11B
Revenue (ttm) 3.58T
Net Income (ttm) 39.29B
Shares Out 207.95M
EPS (ttm) 186.44
PE Ratio 14.24
Forward PE 16.17
Dividend 60.00 (2.27%)
Ex-Dividend Date Sep 27, 2024
Volume 278,900
Open 2,626.00
Previous Close 2,643.50
Day's Range 2,599.00 - 2,661.00
52-Week Range 2,170.50 - 2,770.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 1, 2024

About MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for comp... [Read more]

Sector Healthcare
Founded 1898
Employees 13,075
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 7459
Full Company Profile

Financial Performance

In 2023, MediPal Holdings's revenue was 3.56 trillion, an increase of 5.91% compared to the previous year's 3.36 trillion. Earnings were 41.47 billion, an increase of 6.88%.

Financial Statements

News

There is no news available yet.